About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Nifedipine Shows No Benefit in Preventing Pre-mature Birth

by Hannah Punitha on November 29, 2008 at 7:12 PM
Font : A-A+

 Nifedipine Shows No Benefit in Preventing Pre-mature Birth

A new study has shown that nifedipine, a drug which is widely used to prevent premature births, works no better than a placebo at maintaining pregnancy after the initial bout of pre-term labour is halted.

Medication use should be minimized in pregnancy unless it's clearly indicated, said Dr. Deirdre Lyell, assistant professor of obstetrics and gynecology at Stanford University School of Medicine, and the study's lead author.

Advertisement

Working in collaboration with researchers from Lucile Packard Children's Hospital and Santa Clara Valley Medical Center, Lyell recruited 71 women who had been successfully treated for pre-term labour between 24 and 34 weeks of pregnancy.

The women were then randomly assigned to receive doses of nifedipine or placebo every six hours until 37 weeks of pregnancy or until delivery, whichever came first. The researchers hoped that nifedipine would prevent pre-term labour from re-starting.
Advertisement

Lyell and her colleagues evaluated whether subjects' pregnancies lasted to 37 weeks and measured how long delivery was delayed. They also noted the babies' gestational age at delivery, birth weight, and complications of pre-maturity-such as neurological disorders, chronic lung disease, and vision and hearing problems.

She said that there were no differences between nifedipine and placebo for any measurement.

She revealed that about 40 percent of women in both groups reached 37 weeks of pregnancy, with delivery delayed an average of a month, and that babies' average health was the same in both groups.

Lyell cautioned that the study was designed to detect a 50 percent improvement in delayed deliveries, and that any smaller advantages of nifedipine use would not have been spotted.

She thinks a larger study of nifedipine is warranted.

A small benefit would be especially significant at early gestational ages, and less so later on. But overall, there's no benefit to pre-maturity, she said.

Since there is a lack of data to support nifedipine use, Lyell believes obstetricians should proceed with caution.

All medications have side effects, she said.

The drug might be having a fairly good safety record, but some case reports link it to dangerously low blood pressure in pregnant women.

If something has not been shown to be of benefit, it shouldn't be used. Every now and then, there will be a patient who has an unusual side effect,Lyell said.

It's important to distinguish between acute treatment, which is given to a woman in pre-term labour, and maintenance treatment, which is given to a woman following an episode of pre-term labour that has ended. This study addresses maintenance treatment. We still use nifedipine for acute treatment of pre-term labour, she added.

The findings of the study will appear in the December issue of the journal Obstetrics and Gynecology.

Source: ANI
SPH
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
Power of the Placebo
Placebo is an inert medication given more to please than benefit a patient who believes in its ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use